n. a morphine-derived
opioid antagonist that prevents the binding of opioids to
opioid receptors, having primary activity at the mu opioid receptor. Like other opioid antagonists, it can quickly reverse the effects of opioid overdose and is useful in emergency settings to reverse respiratory depression. It has poor oral and sublingual bioavailability and must be dosed parenterally. U.S. trade name:
Narcan. In combination with
buprenorphine, it is used as an alternative to
methadone maintenance therapy (U.S. trade name:
Suboxone).